BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 6976935)

  • 21. A recombinant hybrid anaphylatoxin with dual C3a/C5a activity.
    Bautsch W; Kretzschmar T; Stühmer T; Kola A; Emde M; Köhl J; Klos A; Bitter-Suermann D
    Biochem J; 1992 Nov; 288 ( Pt 1)(Pt 1):261-6. PubMed ID: 1445269
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platelet activation: a new biological activity of guinea-pig C3a anaphylatoxin.
    Becker S; Meuer S; Hadding U; Bitter-Suermann D
    Scand J Immunol; 1978; 7(2):173-80. PubMed ID: 653315
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complement mediated inhibition of immune precipitation and solubilization generate different concentrations of complement anaphylatoxins (C4a, C3a, C5a).
    Schifferli JA; Steiger G; Paccaud JP
    Clin Exp Immunol; 1986 May; 64(2):407-14. PubMed ID: 3488858
    [TBL] [Abstract][Full Text] [Related]  

  • 24. C3, C5 components and C3a, C4a, and C5a fragments of the complement system.
    Janatova J
    Methods Enzymol; 1988; 162():579-625. PubMed ID: 3265757
    [No Abstract]   [Full Text] [Related]  

  • 25. Demonstration of anaphylatoxins C3a, C4a and C5a in the scales of psoriasis and inflammatory pustular dermatoses.
    Takematsu H; Ohkohchi K; Tagami H
    Br J Dermatol; 1986 Jan; 114(1):1-6. PubMed ID: 3484631
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biochemistry and biology of anaphylatoxins.
    Hugli TE
    Complement; 1986; 3(3):111-27. PubMed ID: 3542363
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Demonstration of high-affinity binding sites for C3a anaphylatoxin on guinea-pig platelets.
    Becker S; Hadding U; Schorlemmer HU; Bitter-Suermann D
    Scand J Immunol; 1978; 8(6):551-5. PubMed ID: 734357
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isolation of three separate anaphylatoxins from complement-activated human serum.
    Hugli TE; Gerard C; Kawahara M; Scheetz ME; Barton R; Briggs S; Koppel G; Russell S
    Mol Cell Biochem; 1981 Dec; 41():59-66. PubMed ID: 6977086
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Complement anaphylatoxins in idiopathic mixed cryoglobulinemia.
    Miadonna A; Leggieri E; Tedeschi A; Cottini M; Invernizzi F; Froldi M; Zanussi C
    Int Arch Allergy Appl Immunol; 1985; 76(2):120-5. PubMed ID: 3967939
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of histamine in the spasmogenic effect of the complement peptides C3a and C5a-desArg (classical anaphylatoxin).
    Sorgenfrei J; Damerau B; Vogt W
    Agents Actions; 1982 Apr; 12(1-2):118-21. PubMed ID: 6177210
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anaphylatoxin levels in human aqueous humor.
    Mondino BJ; Sumner H
    Invest Ophthalmol Vis Sci; 1986 Aug; 27(8):1288-92. PubMed ID: 3488296
    [TBL] [Abstract][Full Text] [Related]  

  • 32. C4a: the third anaphylatoxin of the human complement system.
    Gorski JP; Hugli TE; Müller-Eberhard HJ
    Proc Natl Acad Sci U S A; 1979 Oct; 76(10):5299-302. PubMed ID: 291947
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anaphylatoxin-induced release of histamine from in vitro perfused guinea pig kidney.
    Abdullah NA; Assem ES; Damerau B
    Agents Actions; 1988 Apr; 23(3-4):181-4. PubMed ID: 2455983
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiac anaphylaxis. Complement activation as an amplification system.
    del Balzo U; Polley MJ; Levi R
    Circ Res; 1989 Sep; 65(3):847-57. PubMed ID: 2475275
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemotactic effects of the complement-derived peptides C3a, C3ai and C5a (classical anaphylatoxin) on rabbit and guinea-pig polymorphonuclear leukocytes.
    Damerau B; Grünefeld E; Vogt W
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Nov; 305(2):181-4. PubMed ID: 732894
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anaphylatoxin generation in multisystem organ failure.
    Heideman M; Hugli TE
    J Trauma; 1984 Dec; 24(12):1038-43. PubMed ID: 6334754
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anaphylactic actions of platelet-activating factor.
    Stimler NP; Bloor CM; Hugli TE; Wykle RL; McCall CE; O'Flaherty JT
    Am J Pathol; 1981 Oct; 105(1):64-9. PubMed ID: 6975043
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interaction between the coagulation and complement system.
    Amara U; Rittirsch D; Flierl M; Bruckner U; Klos A; Gebhard F; Lambris JD; Huber-Lang M
    Adv Exp Med Biol; 2008; 632():71-9. PubMed ID: 19025115
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contribution of complement factors and reaction pathways to inflammation.
    Bitter-Suermann D
    Agents Actions Suppl; 1982; 11():159-78. PubMed ID: 6758550
    [No Abstract]   [Full Text] [Related]  

  • 40. Anaphylatoxin levels in human vitreous humor.
    Mondino BJ; Sidikaro Y; Sumner H
    Invest Ophthalmol Vis Sci; 1988 Jul; 29(7):1195-8. PubMed ID: 3262096
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.